Cell therapy weekly: MSCs show promise to treat rare pediatric heart condition
This week: Longeveron treats first patient with MSCs, Duchenne muscular dystrophy improved in mouse model and new funding for development of synthetic ‘gene circuits.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.